U.S. seeks patent protection for drugs, experts say

Domestic experts claim that the oncoming Korea-U.S. negotiations on free trade accord will mainly focus on the U.S. demand for more transparency in the Korean government's process of selecting the drugs eligible for the positive list'' and an extension of the patent period for their drugs to increase their prices.

The U.S. purpose is to lengthen the period of patent guarantee for original dr...